Summary
McKesson Corporation's 10-Q filing for the period ending September 29, 1995, indicates a company operating within the pharmaceutical distribution sector. As this is a historical filing from 1995, it provides a snapshot of the company's performance and financial position during that specific quarter, over two decades ago. Investors would need to consider this context carefully, as the company and its competitive landscape have evolved significantly since this filing. The report details the company's financial results and operational status during this three-month period. While the provided text is a directory listing and not the full financial report, it signifies McKesson's compliance with SEC reporting requirements. For a comprehensive understanding, access to the full 10-Q document (likely the .txt file referenced) is crucial. This would reveal key financial metrics such as revenue, net income, assets, liabilities, and cash flows, as well as management's discussion and analysis of the results.
Key Highlights
- 1McKesson Corporation filed its quarterly report (10-Q) for the period ending September 29, 1995, on November 12, 1995.
- 2The filing is a standard SEC disclosure providing financial and operational information for the specified quarter.
- 3This report provides a historical financial snapshot of McKesson Corporation from over 25 years ago.
- 4The context of 1995 is critical, as the pharmaceutical industry and McKesson's business have undergone substantial changes since then.
- 5Investors interested in historical performance would need to access the full 10-Q filing (indicated by the .txt file) for detailed financial data.
- 6The provided text is a directory listing of the filing's components, not the financial statements themselves.